Neuroversion, Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Effect of Stellate Ganglion Block on ME/CFS (NCT05664711) | Neuroversion, Inc. | 2023-03-15 |
Track Neuroversion, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.